Low-dose growth hormone inhibits 11 beta-hydroxysteroid dehydrogenase type 1 but has no effect upon fat mass in patients with simple obesity.
GH has potent effects on adipocyte biology, stimulating lipolysis but also promoting preadipocyte proliferation. In addition, GH, acting through IGF-I, inhibits 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1), which converts the inactive glucocorticoid, cortisone (E), to active cortisol (...
Автори: | Tomlinson, J, Crabtree, N, Clark, P, Holder, G, Toogood, A, Shackleton, C, Stewart, P |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2003
|
Схожі ресурси
Схожі ресурси
-
Cortisol metabolism and the role of 11beta-hydroxysteroid dehydrogenase.
за авторством: Tomlinson, J, та інші
Опубліковано: (2001) -
Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue.
за авторством: Tomlinson, J, та інші
Опубліковано: (2004) -
Cortisol, 11 beta-hydroxysteroid dehydrogenase type 1 and central obesity.
за авторством: Stewart, P, та інші
Опубліковано: (2002) -
The functional consequences of 11beta-hydroxysteroid dehydrogenase expression in adipose tissue.
за авторством: Tomlinson, J, та інші
Опубліковано: (2002) -
The role of 11 beta-hydroxysteroid dehydrogenase in central obesity and osteoporosis.
за авторством: Tomlinson, J, та інші
Опубліковано: (2000)